Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Stefania Bena"'
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Mast cell stabilizers like cromoglycate and nedocromil are mainstream treatments for ocular allergy. Biochemical studies in vitro suggest that these drugs prevent mast cell degranulation through the release of Annexin-A1 (Anx-A1) protein. However, th
Externí odkaz:
https://doaj.org/article/7e81066a8ed54826919fd3dadffd12e6
Autor:
Dennis H M Kusters, Martijn L Chatrou, Brecht A G Willems, Marijke De Saint-Hubert, Matthias Bauwens, Emiel van der Vorst, Stefania Bena, Erik A L Biessen, Mauro Perretti, Leon J Schurgers, Chris P M Reutelingsperger
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0130484 (2015)
To investigate therapeutic effects of annexin A1 (anxA1) on atherogenesis in LDLR-/- mice.Human recombinant annexin A1 (hr-anxA1) was produced by a prokaryotic expression system, purified and analysed on phosphatidylserine (PS) binding and formyl pep
Externí odkaz:
https://doaj.org/article/5f757913e6a44b8b800fc542683635ea
Autor:
Sonia Maria Oliani, Rod J Flower, Samia Yazid, Ajantha Sinniah, Stefania Bena, Mauro Perretti
Publikováno v:
Frontiers in Pharmacology
Scopus
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
Frontiers in Pharmacology, Vol 10 (2019)
Scopus
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
Frontiers in Pharmacology, Vol 10 (2019)
Made available in DSpace on 2020-12-12T01:06:45Z (GMT). No. of bitstreams: 0 Previous issue date: 2019-01-01 Amt der Steiermärkischen Landesregierung Mast cell stabilizers like cromoglycate and nedocromil are mainstream treatments for ocular allergy
Autor:
Stefania Bena, Jenna L. Cash, Sarah E. Headland, Simon McArthur, Mauro Perretti, Vincenzo Brancaleone
Publikováno v:
EMBO Reports
Chemerin15 inhibits neutrophil-mediated vascular inflammation and myocardial ischemia-reperfusion injury through ChemR23 Neutrophils are shown to express ChemR23 and respond to C15, which inhibits integrin activation and clustering, reducing neutroph
Autor:
Ludovica Ceroni, Stefania Benazzato, Samuel Pressi, Laura Calvillo, Ester Marotta, Enzo Menna
Publikováno v:
Nanomaterials, Vol 14, Iss 6, p 522 (2024)
Carbon nanomaterials are promising adsorbents for dye removal from wastewater also due to their possible surface functionalization that, in principle, can increase the adsorption rate and provide regeneration. To investigate the real advantages of fu
Externí odkaz:
https://doaj.org/article/d3129128e0bd4f4f8de0f784d5722d05
Publikováno v:
The Journal of Biological Chemistry
Background: FPR2/ALX is activated by many ligands, including annexin A1 (AnxA1), which activates resolution circuits in inflammation. Results: Cells transfected with FPR2/ALX and clones with domains swapped with FPR1 afforded identification of N-term
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 31:2749-2759
Objective— The anti-inflammatory properties of the female sex hormone estrogen have been linked to a reduced incidence of cardiovascular disease. In the present study, we addressed whether estrogen could activate vasculoprotective mechanisms via an
Autor:
Jesmond Dalli, Roderick J. Flower, Mauro Perretti, Giuseppe Cirino, Stefania Bena, Vincenzo Brancaleone
Publikováno v:
The Journal of Immunology. 186:4905-4914
The importance of proresolving mediators in the overall context of the resolution of acute inflammation is well recognized, although little is known about whether these anti-inflammatory and proresolving molecules act in concert. In this article, we
Autor:
Mauro Perretti, Chris P. M. Reutelingsperger, Leon J. Schurgers, Dennis H. M. Kusters, Martijn L. Chatrou, Erik A.L. Biessen, Brecht A. G. Willems, Matthias Bauwens, Emiel P. C. van der Vorst, Marijke De Saint-Hubert, Stefania Bena
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0130484 (2015)
PLoS ONE
PLOS ONE, 10(6):e0130484. Public Library of Science
PLoS ONE
PLOS ONE, 10(6):e0130484. Public Library of Science
OBJECTIVE: To investigate therapeutic effects of annexin A1 (anxA1) on atherogenesis in LDLR-/- mice. METHODS: Human recombinant annexin A1 (hr-anxA1) was produced by a prokaryotic expression system, purified and analysed on phosphatidylserine (PS) b
Autor:
Irene, Locatelli, Salvatore, Sutti, Aastha, Jindal, Marco, Vacchiano, Cristina, Bozzola, Chris, Reutelingsperger, Dennis, Kusters, Stefania, Bena, Parola, Maurizio, Claudia, Paternostro, Bugianesi, Elisabetta, Simon, Mcarthur, Emanuele, Albano, Mauro, Perretti
Publikováno v:
Hepatology (Baltimore, Md.)
Annexin A1 (AnxA1) is an effector of the resolution of inflammation and is highly effective in terminating acute inflammatory responses. However, its role in chronic settings is less investigated. Because changes in AnxA1 expression within adipose ti